This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Immunoqure Ag. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2024
Title: Steffen Meyer: Innovator in Human Antibody Research
Introduction
Steffen Meyer is a prominent inventor based in Munich, Germany, known for his significant contributions to the field of biotechnology. With a total of three patents to his name, he has made remarkable strides in the development of human-derived antibodies.
Latest Patents
Meyer’s latest patents include innovative human anti-IFN-α antibodies. These patents provide novel IFN-α binding molecules of human origin, particularly focusing on human-derived anti-IFN-α antibodies, as well as IFN-α binding fragments, derivatives, and variants. Additionally, these patents describe pharmaceutical compositions, kits, and methods for use in diagnosis and therapy.
Career Highlights
Steffen Meyer is currently associated with Immunoqure AG, where he continues to advance research in antibody therapies. His work is pivotal in the development of treatments that leverage the human immune system to combat various diseases.
Collaborations
Meyer collaborates with esteemed colleagues such as Syeda F Y Haque and Adrian Hayday, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Steffen Meyer’s work in the field of human antibodies exemplifies the impact of innovative research on healthcare. His patents and collaborations highlight the importance of scientific advancement in developing effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile